Greg Wolf to Tumor Suppressor Proteins
This is a "connection" page, showing publications Greg Wolf has written about Tumor Suppressor Proteins.
Connection Strength
0.324
-
Gong W, Taner HF, Wu Y, He Y, Zhou X, Li Z, Hu X, Ursin C, Debnath KC, Okuyama K, Hu Q, Donnelly CR, N?r F, Perera CD, Bellile E, Yunesi A, Zhai Z, Zhao M, Cheng W, Fitzsimonds ZR, Broses L, Li J, Demehri S, Nagrath D, Wolf GT, Sikora AG, Yu Y, Wen H, Wei L, Chinn SB, Myers JN, Akira S, Xie Y, Moon JJ, Lei YL. BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity. Nat Commun. 2025 Dec 29; 17(1):1271.
Score: 0.212
-
Medeiros MC, The S, Bellile E, Russo N, Schmitd L, Danella E, Singh P, Banerjee R, Bassis C, Murphy GR, Sartor MA, Lombaert I, Schmidt TM, Eisbruch A, Murdoch-Kinch CA, Rozek L, Wolf GT, Li G, Chen GY, D'Silva NJ. Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancer. Microbiome. 2023 11 30; 11(1):268.
Score: 0.046
-
Liu S, Bellile E, Nguyen A, Zarins K, D'Silva N, Rozek L, Wolf GT, Sartor MA. Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen. Oral Oncol. 2021 12; 123:105587.
Score: 0.040
-
Virani S, Light E, Peterson LA, Sartor MA, Taylor JM, McHugh JB, Wolf GT, Rozek LS. Stability of methylation markers in head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1325-31.
Score: 0.026